Management ChangeApr 7, 2026, 08:31 AM
Azenta Announces Management Change: William Martin Appointed President of Multiomics Business, Ginger Zhou Steps Down
AI Summary
Azenta, Inc. announced that Ginger Zhou stepped down as President of the Multiomics business, and William "Trey" E. Martin III was appointed as her replacement, effective April 6, 2026. Martin's prior experience as CEO of Maravai LifeSciences Holdings suggests a strategic move to leverage his expertise in the life sciences sector, while Zhou will continue in an advisory role.
Key Highlights
- Ginger Zhou stepped down as President of the Multiomics business on April 6, 2026, and will serve as an advisor through November 2026 with a consulting fee of $103,500.
- William "Trey" E. Martin III was appointed President of the Multiomics business, reporting to the Company’s President and CEO, John Marotta.
- Martin previously served as CEO of Maravai LifeSciences Holdings, bringing relevant experience in the life sciences industry.